ACAD

Acadia Pharmaceuticals Inc
19.93
0.10 (0.5%)
Upgrade to Real-Time
Regular Market
19.93
Volume 26,823
Bid Price 19.90
Ask Price 19.96
News -
Day High 20.00

Low
12.24

52 Week Range

High
28.055

Day Low 19.73
Company Name Stock Ticker Symbol Market Type
Acadia Pharmaceuticals Inc ACAD NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.10 0.5% 19.93 09:47:12
Open Price Low Price High Price Close Price Prev Close
19.75 19.73 20.00 19.83
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
569 26,823 $ 19.78 $ 530,646 - 12.24 - 28.055
Last Trade Time Type Quantity Stock Price Currency
09:48:08 1 $ 19.96 USD

Period:

Draw Mode:

Acadia Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 3.23B 161.93M 119.74M $ 484.15M $ -221.59M -1.05 -14.70
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - -20.66k 0.50%

more financials information »

Acadia Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ACAD Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week18.5520.1118.420119.271,218,3111.387.44%
1 Month17.1320.1116.69518.601,283,3892.8016.35%
3 Months16.3220.1114.4516.731,103,3663.6122.12%
6 Months16.0320.1113.7316.581,348,7823.9024.33%
1 Year23.6028.05512.2417.941,730,484-3.67-15.55%
3 Years43.1058.7212.2427.481,600,322-23.17-53.76%
5 Years26.7358.7212.2426.061,800,971-6.80-25.44%

Acadia Pharmaceuticals Description

Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.